Cytiva investing in additional resins manufacturing operations
Cytiva is investing in additional resins manufacturing operations, with the acquisition of a new facility in Muskegon, Michigan.
Cytiva is investing in additional resins manufacturing operations, with the acquisition of a new facility in Muskegon, Michigan.
Eden Biologics reports that it has completed the divestment of its CDMO business assets to Bora Pharmaceuticals.